According to US researchers, the big coffee drinkers (more than 4 cups per day) are less at risk of developing multiple sclerosis.

Coffee is a fuel that many of us can not do without to start the day. But in recent years, several studies have shown that it also would possess therapeutic properties especially against diabetes and melanoma . Now researchers at the University of Baltimore, whose work has been presented at 67th Annual Meeting of the American Academy of Neurology (Washington, USA), even claim that it could protect against multiple sclerosis (MS).

Reduced risk of 1.5 from 4 cups of coffee per day

To reach these conclusions, Dr. Ellen Mowry and her team are based on two previous studies analyzing the coffee protective effect on the brain: one is Swedish, the other American. The Swedish study was conducted on 1,629 people with MS and a control group of 2,807 healthy people, while the amércaine study involved 1,159 people with MS and 1,172 healthy people.

In compiling the data from these two studies, Dr. Mowry team arrived two identical conclusions: people drinking at least four cups of coffee a day had 1.5 times less likely to develop MS than who drink less coffee or not at all. The Swedish study, conducted over a period of ten years, also mentions a protective effect beyond 5 years.

2 million people affected by MS in the world, of course, that is the main ingredient caffeine that coffee should this protective virtue. “Caffeine has neuroprotective properties and appears to suppress the production of pro-inflammatory cytokines observed mechanisms that may explain the association,” says Dr. Ellen Mowry, senior author of the study. Indeed, previous studies have already proven the effectiveness of caffeine on the brain and especially against diseases such as disease or Parkinson Azheimer . But the links between caffeine and multiple sclerosis remained hitherto little known.

MS affects 2 million people in the world. In France, it affects about 80,000 people with an incidence of 4,000 new cases of inflammatory demyelinating events each year. Despite considerable therapeutic progress in recent years, no treatment helps heal. With this new discovery, Dr. Mowry remains very optimistic: “This could open the way for the development of caffeine-based drugs in the treatment of MS,” she says.